Publications by authors named "V Steiner"

Purpose: To investigate the surgical success and efficacy of XEN45 implantation (XEN45 μm, AbbVie Inc., USA) with and without combined cataract surgery up to the first 5 years.

Methods: In a prospective observational monocentric trial, 192 eyes of 157 patients with open-angle glaucoma received either XEN45 implants only (solo surgery group) or combined surgery/cataract surgeries (combined surgery group).

View Article and Find Full Text PDF

The purpose of this experimental paper is to examine the adhesion properties between non-woven plastic sheets and cement mortar. Specifically, the effect of w/c ratio and quantity of superplasticizer on the peeling force required for the detachment of tissue from the surface of prisms was studied in detail. Therefore, two types of mortar mixtures were prepared: (1) mixtures without superplasticizer with three different w/c ratios of 0.

View Article and Find Full Text PDF

The aim of the case series is to highlight the surgical challenges experienced like failed intervention, choroidal effusion, a postoperative cystoid macular oedema, and describe treatment options for Radius-Maumenee syndrome. Authors reported on 3 bilateral cases of Radius-Maumenee syndrome which underwent medical treatment, trabeculectomy with Mitomycin C, implantation with XEN45, Ahmed glaucoma valve, Baerveldt glaucoma implant, and cyclophotocoagulation.

View Article and Find Full Text PDF

This study will investigate the effect of non-woven PET plastic tissue on the fresh, physical, mechanical, acoustic, thermal, and microstructural behaviors of concrete. Including reference specimens, non-woven fabrics were considered in two ways: (a) as a layer with four various configurations of 1-layer, 2-sides, 3-sides, and full wrapping (4-sides) to strengthen specimens, and (b) as (10 × 10) mm cut pieces with three different incorporated percentages of 0.25%, 0.

View Article and Find Full Text PDF

Purpose: This study investigates the course of the endothelial cell density over a period of 5 years after XEN45 implantation (XEN45µm, Allergan Plc., USA) with or without combined cataract surgery.

Methods: This is a prospective, cross-sectional, monocentric, non-randomized clinical trial with the intention to treat a population of the University Eye Clinic Glaucoma Service Salzburg.

View Article and Find Full Text PDF